Tag:

Advisory Committee on Immunization Practices

COVID-19: CDC Panel Recommends Moderna, Pfizer Vaccines Over Johnson & Johnson Jab COVID-19: CDC Panel Recommends Moderna, Pfizer Vaccines Over Johnson & Johnson Jab
Covid-19: CDC Panel Recommends Moderna, Pfizer Vaccines Over Johnson & Johnson Jab The Centers for Disease Control and Prevention (CDC) issued new guidance saying that people shouldn’t get the one-dose Johnson & Johnson COVID-19 shot if the Pfizer or Moderna option is available. Citing potentially life-threatening blood clots liked to the J & J jab, the CDC’s Advisory Committee on Immunization Practices (ACIP) met on Thursday, Dec. 16 following an update from the Food and Drug Administration. Federal officials halted the use of the Johnson & Johnson vaccine earlier this year for 10 days in April after six women experienced the blood-clotting problem — the only…
COVID-19: CDC Advisory Panel Endorses Use Of Pfizer Vaccine In Children 12 And Up COVID-19: CDC Advisory Panel Endorses Use Of Pfizer Vaccine In Children 12 And Up
Covid-19: CDC Advisory Panel Endorses Use Of Pfizer Vaccine In Children 12 And Up A panel of experts advising the Centers for Disease Control and Prevention (CDC) voted to move forward with the approval process for the use of the Pfizer COVID-19 vaccine among children between the ages of 12 and 15. By a 14-0 vote on Wednesday afternoon, May 12, the CDC panel recommended the use of the Pfizer vaccine in children 12 and up, with the decision now moving forward to CDC Director Dr. Rochelle Walensky for final approval. Once approved by Walensky, which is expected to happen quickly, it will be at states’ discretion about whether or not to move forward vaccinating children. …
COVID-19: Pfizer Dramatically Ramps Up Distribution After Pause On Johnson & Johnson Vaccines COVID-19: Pfizer Dramatically Ramps Up Distribution After Pause On Johnson & Johnson Vaccines
Covid-19: Pfizer Dramatically Ramps Up Distribution After Pause On Johnson & Johnson Vaccines Hundreds of millions of new COVID-19 vaccines are set to be distributed across the country as Pfizer prepares to ramp up the production of its doses amid the pause of the Johnson & Johnson one-dose shot rollout. Pfizer CEO Albert Bourla announced that his company, with headquarters in the New York (in Manhattan and Rockland County), is now on track to deliver 10 percent more vaccine doses to the US (approximately 220 million) while supplying the already agreed upon 300 million doses for the end of July two weeks early. Both Pfizer and Moderna, two of the three approved vaccines by the F…